| Notification to Ravimiamet of the first distribution of a device on the Estonian market(National notification under MSS § 26(4)) This is a national reporting clock, not a review clock: 'Iga ettevõtja, kes levitab Eesti turul ... IIa, IIb või III riskiklassi meditsiiniseadet või ... B-, C- või D-klassi in vitro diagnostikameditsiiniseadet, teavitab sellest Ravimiametit kümne päeva jooksul asjaomase meditsiiniseadme esmakordsest levitamisest arvates' The same ten-day period applies to a system or procedure pack within the meaning of MDR Article 22 and to an active implantable device, so one clock spans several risk classes rather than belonging to any single one It binds the undertaking that distributes the device, which may be an importer or distributor rather than the manufacturer, and the notification does not gate the distribution A separate ten-day period runs in advance of placing a custom-made device on the market (MSS § 26(3)), and a ten-working-day period applies to submitting the list of in-house manufactured devices (MSS § 26(1)) |